Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

HTUS delivered a very high yield that is atypical of the strategy based on historical data. Read why caution is warranted with HTUS ETF.

Forget AI stocks. It was the old-world store of value and the new-age digital gold that stole the show in FY25.

TBG has solid quality and dividend growth features, though negative historical earnings growth rates led to a high 66% payout ...

Bitcoin Just Hit a New Record High. 5 Reasons It Could Soar Even Further in the Second Half of 2025.

The Bank of Japan finished selling off its holdings of stocks bought from 2002 to 2010 in a rare programme to avert ...

Bitcoin surges to $120,000 backed by record ETF inflows, rising network activity, and strong accumulation from long-term ...

With the SEC’s closed meeting and Crypto Week votes looming, XRP price eyes a breakout amid ETF buzz and bullish investor ...

This index fund screener is based on tracking error and returns difference wrt benchmarks (aka tracking difference). It will help users evaluate how ...

Marc Pinto, global head of private credit at Moody’s, recently suggested private credit could be a major beneficiary of Trump ...

Speculation over an SEC appeal withdrawal and XRP-spot ETF approval drives XRP higher, with the token up 21.61% this week ...

With the AT1 hybrid market being phased out, investors will be looking for solutions. VanEck has a handful of ETFs that could fill the void.